(This note is not part of the Regulations)
These Regulations further amend the National Health Service (Pharmaceutical Services) Regulations 1992 (“the Pharmaceutical Services Regulations”) which govern the arrangements for the provision of pharmaceutical services under the National Health Service Act 1977 and the National Health Service (General Medical Services) Regulations 1992 (“the General Medical Services Regulations”) which regulate the terms on which doctors provide general medical services under the National Health Service Act 1977.
Regulation 3(3) of these Regulations adds Apomorphine Hydrochloride (Uprima) to Schedule 11 to the General Medical Services Regulations, which lists the drugs and other substances that may only be prescribed in certain circumstances in the course of pharmaceutical services provided under the National Health Service Act 1977.
The amendments within regulation 2 and 3(1) and (2) amend both sets of Regulations to take account of the fact that certain appliances may be available for prescription within the National Health Service only in circumstances that are specified by the National Assembly for Wales in the Drug Tariff.
Regulation 2(c) of these Regulations extends the definition of “nurse prescriber” in the Pharmaceutical Services Regulations to reflect the extended responsibilities granted to certain nurses. The determination of the National Assembly for Wales as to those drugs, medicines and listed appliances which may be ordered by nurse prescribers is currently set out in Part XVIIB of the Drug Tariff, copies of which may be obtained from the Stationery Office, PO Box 29, Norwich NR3 1GN.
Regulation 2(2)(b), (3) and (6) also make changes to the Pharmaceutical Services Regulations consequential upon the commencement of section 42 of the Health and Social Care Act 2001, which substituted section 41 to the National Health Service Act 1977.
Regulation 2(2)(a) corrects a numbering error in the Pharmaceutical Services Regulations.